CalciMedica announces proposed public offering of common stock; preliminary cash $14.6M

CalciMedica, Inc.

Launched underwritten public offering of common stock; all shares sold by the company; no terms disclosed.
Preliminary cash $14.6M as of Sept 30, 2024 (unaudited); expects Q3 10-Q filing around Nov 14.
Suspended ATM sales agreement with H.C. Wainwright during the offering; JonesTrading sole book-runner.
Underwriter granted 30-day option to purchase up to additional 15% of shares sold in offering.
Offering subject to market conditions; no assurance as to completion, size, or terms.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.